Influence of anti-TNF patient warning regarding avoidance of high risk foods on rates of listeria and salmonella infections in the UK

Annals of the Rheumatic Diseases

Volumn 72, Issue 3, 2013, Pages 461-462

  Davies, Rebecca ^a   Dixon, William G ^a   Watson, Kath D ^a   Lunt, Mark ^a   Symmons, Deborah P M ^a   Hyrich, Kimme L ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; AGED; BACTERIAL ARTHRITIS; COHORT ANALYSIS; DIET RESTRICTION; FEMALE; FOLLOW UP; FOOD CONTAMINATION; GASTROINTESTINAL INFECTION; HUMAN; INFECTION RATE; INFECTION RISK; LETTER; LISTERIA; LISTERIOSIS; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NUTRITIONAL COUNSELING; PATIENT EDUCATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK REDUCTION; SALMONELLA; SALMONELLOSIS; SEPTICEMIA; TREATMENT DURATION; UNITED KINGDOM;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CONSUMER HEALTH INFORMATION; GREAT BRITAIN; HUMANS; IMMUNOGLOBULIN G; INCIDENCE; LISTERIOSIS; RECEPTORS, TUMOR NECROSIS FACTOR; SALMONELLA FOOD POISONING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84873724580     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-202228     Document Type: Letter

References (10)

1. Strangfeld A, Listing J. Bacterial and opportunistic infections during anti-TNF therapy. Best Pract & Res Clin Rheumatol 2006; 20: 1181-95.
2. Listing J, Strangfeld A. Infections in all patients with rheumatoid arthritis treated with biologic agents. Arthritis & Rheum 2005; 52: 3403-12.
3. Keane J, Gershon S, Wise R., et al Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralising agent. N Eng J Med 2001; 345: 1098-104.
4. Silfman N, Gershon S, Lee J., et al Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor a-neutralising agents. Arthritis & Rheum 2003; 48: 319-24.
5. Netea M, Radstake T, Joosten L., et al Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: association with decreased interferon-y production and Toll-like receptor 4 expression. Arthritis & Rheum 2003; 48: 1853-57.
6. Dixon WG, Watson K, Lunt M., et al Rate of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis therapy. Arthritis & Rheum 2006; 54: 2368-76.
7. http://www.arthritisresearchuk.org/arthritis-information/drugs/ etanercept.aspx, 2011 (accessed 8 Jan 2012).
8. http://www.arthritisresearchuk.org/arthritis-information/drugs/ infliximab.aspx, 2011 (accessed 8 Jan 2012).
9. http://www.arthritisresearchuk.org/arthritis-information/drugs/ adalimumab.aspx, 2011 (accessed 8 Jan 2012).
10. Hyrich KL, Watson K, Isenberg D., et al The British Society for Rheumatology Biologics Register: 6 years on. Rheumatology 2008; 47: 1441-43.